MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction, distillation, purification and cannabinoid isolation, is pleased to announce that its wholly owned subsidiary, MediPharm Labs Inc., has entered into purchase agreements to secure a substantial 9,000 KG of dried cannabis supply from […]
The post MediPharm Labs Secures 9,000 KG of Dried Cannabis Adding Substantial Private Label Cannabis Extract Production appeared first on Technical420.
You may also like
-
Mississippi Is Working To Legalize Marijuana In 2021
-
Curaleaf Holdings, Inc. (CURLF) Announces Opening of Branded Store in Wells, Main
-
Tilray Continues To Pile On Bullish Institutional Investors
-
Canopy Growth Corporation (CGC) to Report First Quarter Fiscal Year 2022 Financial Results on August 6, 2021
-
TILT Holdings Inc. (TLLTF) Enters Into New $10 Million Revolving Credit Facility